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1. Introduction 
It is currently accepted that binding of steroid- 
receptors constitutes the first step whereby anumber 
of hormone dependant processes are initiated in the 
appropriate target issue. Although with the usual 
approach of competitive binding and Scatchard 
analysis a unitary (K D (37°C) 5 × 10 -1° M) site [1] or 
a 10 -9 M site [2] has been reported, we have recently 
provided exclusive chromatographic evidence for the 
existence of a polymorphic mineralocorticoid 
(aldosterone) specific receptor (MR) present in the 
target issue kidney [3], an organ also endowed with 
glucocorticoid (corticosterone) specific receptors 
(GR) in common with the liver [4]. In mammals, ion 
regulation is principally accomplished by aldosterone, 
but deoxycorticosterone 18-hydroxy-deoxycortico- 
sterone also play some role, the latter especially during 
pathogenesis and these, by Scatchard analysis and 
competition, are presumably bound to the same 
unitary receptor though with decreasing affinity 
according to physiological plasma concentration [1,2]. 
Evidence presented in this report reveals that binding 
of the two agonists of the mineralocorticoid occurs to 
units chromatographically distinct from those that 
exhibit aldosterone binding. Thus, contrary to mere 
differences in the affinity and in the in vivo concen- 
trations, mineralocorticoid agonist action may proceed 
via differential binding to physicochemically distinct 
protein entities. 
2. Materials, methods and results 
As previously reported [5] mineralocorticoid 
(aldosterone) specific receptors (MR) eluted as a more 
abundant species (MRa) in the 0.001 M PO4 region 
followed by a less abundant species (MR2) at 0.06 M 
NaC1 (insert fig.1 a); this second peak was totally 
wanting when desoxycorticosterone (DOC) or its 
18-hydroxy analogue (18-OH-DOC) even at 
10 -7 M (required to saturate the component in
0.001 M prewash) was employed in place of 10 -a M 
aldosterone (fig.1 a, 1 b). Under these conditions, 
prolonged incubation (3 h) of the cell sap-steroid 
mixtures or addition of the steroid to crude homo- 
genates, prior to ultracentrifugation, in order to 
attempt ligand protection by the specific substrate 
did not increase binding upon subsequent chromato- 
graphy. Rather, DOC appeared consistently and 
largely bound to some components still retained by 
DE-52 after 0.2 M NaC1 and which coeluted with 
[~4C] corticoster0ne bound to serum transcortin. 
To this end, 0-0.2 M PO4 gradients were employed 
in order to obtain total elution from the DE-52 
column in place of the NaC1 gradients [5] (where ten- 
fold higher concentrations are required for the elution 
of the same component). Data in fig.2 clearly show 
that even at 10 -7 M concentration, noradioactivity 
was found in neither the 0.006 M PO4 region with 
either DOC (fig.2) or 18-OH-DOC (not shown) where 
aldosterone bound MR2 receptors are usually eluted 
[3], nor the 0.02 M PO4 region where glucocorticoid 
specific GR receptors elute from the kidney or rat 
[4,5] and even human liver [6] cytosols; although 
labelled with most natural steroids, the macromole- 
cules in the 0.001 M PO4 region from both organs 
appear to be adapted to hormone-specific unctions [4] 
Rather, DOC (but not 18-DOC) was bound mostly 
to some component in the 0.04-0.06 M PO4 region 
(MRa) which coeluted with transcortin (T) clearly 
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Fig.1. Ion exchange separation of rat kidney mineralocorticoid binding proteins by NaCI gradients. Male, Wistar rats (150-200 g) 
were bilaterally adrenalectomized at least 48 h before use, exsanguinated under ether anesthesia and perfused with the initial buffer 
by aortic cannulation. Blood serum (2 ml) was incubated with 0.2 #Ci of ['4C]corticosterone for 60 min at 4°C. The 105 000 g 
supernatant fraction (5 ml) of rat kidney was also equilibrated for 60 min at 4°C with 10 -7 M of either [3H]deoxycorticosterone 
(DOC) or [3H] 18-hydroxy-deoxycorticosterone (18-OH-DOC) or I0 -s M [aH]aldosterone. Free radioactivity was removed by 
further incubation (10 min) in presence of activated charcoal (Sigma C-5260), centrifugation at 3000 g (10 min) and passage 
through glass wool, successively. The cytosol and serum were finally mixed and layered on DEAE-52 (1 × 25 cm) column, 
prepared, packed and eluted as before [3-6] .  After passage of 60-70 ml of the initial buffer (fraction volume 6-7 ml) elution 
was begun (at arrow) by a linear gradient between 60 ml each of 0.001 M PO4, pH 7.5 (initial buffer) and this buffer containing 
0.2 M NaC1, at a flow rate of 60 ml/h at 4°C (fraction vol. approximately 3 ml). Aliquots of 1 ml were mixed with 10 ml Unisolve 
(Kochlight) and counted in a Packard Tricarb scintillation spectrometer with corrections for quenching, spilling and background 
[ 3-6 ] ; A ~80 values were recorded manually ( . . . .  ). [ 1,2 a H ] aldosterone (46 Ci/mM; batch B 12) and [ 1,2 aH ] 18-hydroxy 
deoxycorticosterone (51 Ci/mM; batch 2) and [4J4C]corticosterone (52mCi/mM, batch 9) were products of Amersham; 
[ 1,23H]deoxycorticosterone was purchased from CEA, France; all other chemicals were high purity reagent grade. DE AE-52 
was purchased from Whatman (England) and Sephadex G-200 from Pharmacia (Sweden). The experiment with 10-s M aldosterone 
(insert) was done without serum (as before, [5 ] ) (o)3H; (o)14C. 
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(fig.2) but which could not be revealed with 18-OH- 
DOC that has a high affinity for the serum binder. 
In parallel experiments, serum bound DOC > 18-DOC 
aldosterone also peaked in this 0.04-0.06 M PO4 
region from the DE-52 column. Thus, DOC binding 
(fig.2) would probably represent association with 
another moiety. This latter possibility appeared very 
real since DOC binding components could not be 
found in the high phosphate region from the liver 
Fig.2. Ion exchange separation of deoxycorticosterone binder 
in rat kidney. All details as in legend to riga except hat 
kidney cytosol (5 ml) and serum (2 ml) were equilibrated 
with 10 -7 M [aH]deoxycorticosterone and 0.2 pCi of [4-14C] 
corticosterone, r spectively, and eluted with a gradient 
between 0.001 M and 0.2 M PO4, pH 7.5. For liver cytosol 
(insert), under exactly the same conditions as kidney, only 
the relevant portion is shown. (e)aH; (o)14C; ( -  - -)A2,o. 
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which synthesizes and may trap (despite prolonged 
perfusion in vitro) far larger quantities of transcortin 
than kidney (see insert fig.2). 
In still other experiments, components of com- 
parable tool. wt. bind all three steroids resulting in 
essentially similar elution profiles (fig.3a-c). Binding 
to the heavier (113 000) mol. wt. component (H) 
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Fig.3. Molecular filtration of rat kidney mineralocorticoid 
binding proteins. 2 ml kidney cytosol was incubated with 
10 -7 M of either [ 3H]aldosterone, [ 3H] DOC, or [ 3H] 18-OH- 
DOC and layered, without charcoal pretreatment, on to 
Sephadex G-200 columns (1 × 30 cm) packed, equilibrated 
and eluted with 0.01 M PO 4, pH 7.4 containing 0.1 M NaCI; 
further details as before [4]. 
exhibited the order aldosterone > DOC > 18-OH-DOC; 
the lower (67 000) mol. wt. component (L) was 
maximally revealed with DOC > aldosterone > 18-DOC 
(reminiscent of large quantities of DOC binding on 
DE-52 above) and, at least in case of aldosterone, 
coeluted with serum transcortin. In separate xperi- 
ments, serum bound DOC < aldosterone < 18-OH-DOC 
eluted in this position from the G-200 column (not 
shown). Separation was less clear when chromatography 
was attempted on Sephadex A-25 columns based both 
on molecular weight and charge (not shown). 
Mineralocorticoid interaction with receptors [1,2] 
by Scatchard analysis (with relative affinities: 
aldosterone > DOC > 18-OH-DOC) does not reveal 
whether binding occurs to a unitary receptor endowed 
with a flexible site capable of stereospecific adjust- 
ments dictated by the steroid structure in question 
or brings into account he possible presence of 
physicochemically distinct 'isoreceptors', 'proreceptors', 
and 'inhibitors'. Pioneering evidence isprovided here 
to substantiate he thesis that agonist (and by extra- 
polation antagonist) action may proceed via preferen- 
tial activation or inactivation of a subspecies within 
any one class of receptor population since both MR 
and GR exist in a polymorphic state [3-6] and since 
18-OH-DOC binds only to the 0.001 M component 
(with only minimal association to GR). Moreover, 
agonist (DOC but not 18-OH-DOC action may also 
proceed via association with another moiety (MR3) 
that (along with MRs) is clearly lacking in the liver 
(having no physiological role), that coelutes with 
intra- or extra-cellular t anscortin (T), and that cannot 
be distinguished by separation based on molecular 
weights alone. Indeed, it has recently been suggested 
by autoradiography that a type III corticosterone 
binder may have some role in kidney specific 
physiology although from saturation characteristics 
(just as chromatographic profile of MR3 here) it was 
previously confused with transcortin [1 ]. Thus, intra- 
cellular egulation may call into action qualitative 
variations in a number of parameters contrary to mere 
quantitative adjustments attempted by Scatchard 
analysis at equilibrium. 
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